DYRK1A and Dravet syndrome: Studies of the contribution of DYRK1A to abnormal brain development and neurogenesis and results of the estimation of developmental neuronal deficits in this study indicate that therapeutic reduction of overexpressed DYRK1A in DS subjects during their development may reduce developmental abnormalities, including defective neurogenesis, which results in a reduced number of neurons and intellectual deficits.